Dietary supplementation with laminarin, a fermentable marine β (1-3) glucan, protects against hepatotoxicity induced by LPS in rat by modulating immune response in the hepatic tissue

International Immunopharmacology

Volumn 7, Issue 12, 2007, Pages 1497-1506

  Neyrinck, Audrey M ^a   Mouson, Ariane ^a   Delzenne, Nathalie M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

glucan; Kupffer cells; Laminarin; LPS

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BACTERIUM LIPOPOLYSACCHARIDE; BETA 1,3 GLUCAN; LACTATE DEHYDROGENASE; LAMINARAN; MYELOPEROXIDASE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ESCHERICHIA COLI; FERMENTATION; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; HYPOTHERMIA; IMMUNE RESPONSE; IMMUNOMODULATION; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; BODY TEMPERATURE; DIETARY SUPPLEMENTS; DINOPROSTONE; ENDOTOXEMIA; IMMUNOLOGIC FACTORS; KUPFFER CELLS; L-LACTATE DEHYDROGENASE; LEUKOCYTE COUNT; LIPOPOLYSACCHARIDES; LIVER; MALE; NITROGEN DIOXIDE; ORGAN SIZE; PEROXIDASE; POLYSACCHARIDES; RATS; RATS, WISTAR; SPLEEN; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34848914779     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.06.011     Document Type: Article

References (48)

1. Ramphal R., and Ambrose P.G. Extended-spectrum beta-lactamases and clinical outcomes: current data. Clin Infect Dis 42 Suppl 4 (Apr 15 2006) S164-S172
2. Tacconelli E. New strategies to identify patients harbouring antibiotic-resistant bacteria at hospital admission. Clin Microbiol Infect 12 2 (Feb 2006) 102-109
3. Soltys J., and Quinn M.T. Modulation of endotoxin-and enterotoxin-induced cytokine release by in vivo treatment with beta-(1,6)-branched beta-(1,3)-glucan. Infect Immun 67 1 (Jan 1999) 244-252
4. Navarro W.H., and Kaplan L.D. AIDS-related lymphoproliferative disease. Blood 107 1 (Jan 1 2006) 13-20
5. Calder P.C., and Kew S. The immune system: a target for functional foods?. Br J Nutr 88 Suppl 2 (Nov 2002) S165-S177
6. Neyrinck A.M., Alexiou H., and Delzenne N.M. Kupffer cell activity is involved in the hepatoprotective effect of dietary oligofructose in rats with endotoxic shock. J Nutr 134 5 (May 2004) 1124-1129
7. Sheth K., and Bankey P. The liver as an immune organ. Curr Opin Crit Care 7 2 (Apr 2001) 99-104
8. Gregory S.H., and Wing E.J. Neutrophil-Kupffer cell interaction: a critical component of host defenses to systemic bacterial infections. J Leukoc Biol 72 2 (Aug 2002) 239-248
9. Mathison J.C., and Ulevitch R.J. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J Immunol 123 5 (Nov 1979) 2133-2143
10. Su G.L. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 283 2 (Aug 2002) G256-G265
11. Callery M.P., Kamei T., Mangino M.J., and Flye M.W. Organ interactions in sepsis. Host defense and the hepatic-pulmonary macrophage axis. Arch Surg 126 1 (Jan 1991) 28-32
12. Suzuki T., Takahashi T., Yamasaki A., Fujiwara T., Hirakawa M., and Akagi R. Tissue-specific gene expression of heme oxygenase-1 (HO-1) and non-specific delta-aminolevulinate synthase (ALAS-N) in a rat model of septic multiple organ dysfunction syndrome. Biochem Pharmacol 60 2 (Jul 15 2000) 275-283
13. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 192 2 (Sep 11 1990) 245-261
14. Laskin D.L., and Pendino K.J. Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol 35 (1995) 655-677
15. Brown G.D., and Gordon S. Immune recognition of fungal beta-glucans. Cell Microbiol 7 4 (Apr 2005) 471-479
16. Deville C., Damas J., Forget P., Dandrifosse G., and Peulen O. Laminarin in the dietary fibre concept. J Sci Food Agric 84 9 (Jul 2004) 1030-1038
17. Heuff G., van der Ende M.B., Boutkan H., Prevoo W., Bayon L.G., Fleuren G.J., et al. Macrophage populations in different stages of induced hepatic metastases in rats: an immunohistochemical analysis. Scand J Immunol 38 1 (Jul 1993) 10-16
18. Anderson W.A., Kang Y.H., and Mohla S. Mammalian endogenous peroxidases as cellular markers and as biosynthetic endpoints of hormone-mediated activity: viewpoint from cytochemistry. Prog Histochem Cytochem 11 4 (1979) 1-27
19. Daubioul C.A., Taper H.S., De Wispelaere L.D., and Delzenne N.M. Dietary oligofructose lessens hepatic steatosis, but does not prevent hypertriglyceridemia in obese zucker rats. J Nutr 130 5 (May 2000) 1314-1319
20. Bishop-Bailey D., Larkin S.W., Warner T.D., Chen G., and Mitchell J.A. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. Br J Pharmacol 121 1 (May 1997) 125-133
21. Neyrinck A.M., Margagliotti S., and Delzenne N.M. Insight into the involvement of Kupffer cell-derived mediators in the hepatoprotective effect of glycine upon inflammation: study on rat precision-cut liver slices. Inflamm Res 54 3 (Mar 2005) 106-112
22. Cisneros R.L., Gibson III F.C., and Tzianabos A.O. Passive transfer of poly-(1-6)-beta-glucotriosyl-(1-3)-beta-glucopyranose glucan protection against lethal infection in an animal model of intra-abdominal sepsis. Infect Immun 64 6 (Jun 1996) 2201-2205
23. Babineau T.J., Hackford A., Kenler A., Bistrian B., Forse R.A., Fairchild P.G., et al. A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients. Arch Surg 129 11 (Nov 1994) 1204-1210
24. Babineau T.J., Marcello P., Swails W., Kenler A., Bistrian B., and Forse R.A. Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients. Ann Surg 220 5 (Nov 1994) 601-609
25. Kernodle D.S., Gates H., and Kaiser A.B. Prophylactic anti-infective activity of poly-[1-6]-beta-d-glucopyranosyl-[1-3]-beta-d-glucopryanose glucan in a guinea pig model of staphylococcal wound infection. Antimicrob Agents Chemother 42 3 (Mar 1998) 545-549
26. Tzianabos A.O., and Cisneros R.L. Prophylaxis with the immunomodulator PGG glucan enhances antibiotic efficacy in rats infected with antibiotic-resistant bacteria. Ann N Y Acad Sci 797 (Oct 25 1996) 285-287
27. Demir G., Klein H.O., Mandel-Molinas N., and Tuzuner N. Beta glucan induces proliferation and activation of monocytes in peripheral blood of patients with advanced breast cancer. Int Immunopharmacol 7 1 (Jan 2007) 113-116
28. Sener G., Toklu H., Ercan F., and Erkanli G. Protective effect of beta-glucan against oxidative organ injury in a rat model of sepsis. Int Immunopharmacol 5 9 (Aug 2005) 1387-1396
29. Kournikakis B., Mandeville R., Brousseau P., and Ostroff G. Anthrax-protective effects of yeast beta 1,3 glucans. MedGenMed 5 1 (Mar 21 2003) 1
30. Sheth K., and Bankey P. The liver as an immune organ. Curr Opin Crit Care 7 2 (Apr 2001) 99-104
31. Simpson K.J., Lukacs N.W., Colletti L., Strieter R.M., and Kunkel S.L. Cytokines and the liver. J Hepatol 27 6 (Dec 1997) 1120-1132
32. Bautista A.P., Meszaros K., Bojta J., and Spitzer J.J. Superoxide anion generation in the liver during the early stage of endotoxemia in rats. J Leukoc Biol 48 2 (Aug 1990) 123-128
33. Seki S., Habu Y., Kawamura T., Takeda K., Dobashi H., Ohkawa T., et al. The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses. Immunol Rev 174 (Apr 2000) 35-46
34. Barton B.E., and Jackson J.V. Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model. Infect Immun 61 4 (Apr 1993) 1496-1499
35. Alexander B. The role of nitric oxide in hepatic metabolism. Nutrition 14 4 (Apr 1998) 376-390
36. Takano M., Nishimura H., Kimura Y., Washizu J., Mokuno Y., Nimura Y., et al. Prostaglandin E2 protects against liver injury after Escherichia coli infection but hampers the resolution of the infection in mice. J Immunol 161 6 (Sep 15 1998) 3019-3025
37. Bosch M.A., Garcia R., Pagani R., Portoles M.T., Diaz-Laviada I., Abarca S., et al. Induction of reversible shock by Escherichia coli lipopolysaccharide in rats. Changes in serum and cell membrane parameters. Br J Exp Pathol 69 6 (Dec 1988) 805-812
38. Mandl J., Wall C., Lerant I., Falus A., Machovich R., and Thurman R.G. Endotoxin and fibrinogen degradation product-D have different actions on carbohydrate metabolism: role of Kupffer cells. FEBS Lett 376 1-2 (Nov 27 1995) 65-66
39. Spolarics Z., and Spitzer J.J. Acute endotoxin tolerance is accompanied by stimulated glucose use in macrophage rich tissues. Biochem Biophys Res Commun 211 1 (Jun 6 1995) 340-346
40. Tollner B., Roth J., Storr B., Martin D., Voigt K., and Zeisberger E. The role of tumor necrosis factor (TNF) in the febrile and metabolic responses of rats to intraperitoneal injection of a high dose of lipopolysaccharide. Pflugers Arch 440 6 (Oct 2000) 925-932
41. Harris H.W., Gosnell J.E., and Kumwenda Z.L. The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity. J Endotoxin Res 6 6 (2000) 421-430
42. Berbee J.F., Havekes L.M., and Rensen P.C. Apolipoproteins modulate the inflammatory response to lipopolysaccharide. J Endotoxin Res 11 2 (2005) 97-103
43. Buddington R.K., Kelly-Quagliana K., Buddington K.K., and Kimura Y. Non-digestible oligosaccharides and defense functions: lessons learned from animal models. Br J Nutr 87 Suppl 2 (May 2002) S231-S239
44. Rice P.J., Adams E.L., Ozment-Skelton T., Gonzalez A.J., Goldman M.P., Lockhart B.E., et al. Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge. J Pharmacol Exp Ther 314 3 (Sep 2005) 1079-1086
45. Engstad C.S., Engstad R.E., Olsen J.O., and Osterud B. The effect of soluble beta-1,3-glucan and lipopolysaccharide on cytokine production and coagulation activation in whole blood. Int Immunopharmacol 2 11 (Oct 2002) 1585-1597
46. Yan J., Vetvicka V., Xia Y., Hanikyrova M., Mayadas T.N., and Ross G.D. Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan. Immunopharmacology 46 1 (Jan 2000) 39-54
47. Neyrinck A.M., Gomez C., and Delzenne N.M. Precision-cut liver slices in culture as a tool to assess the physiological involvement of Kupffer cells in hepatic metabolism. Comp Hepatol 3 Suppl 1 (Jan 14 2004) S45
48. Neyrinck A., Eeckhoudt S.L., Meunier C.J., Pampfer S., Taper H.S., Verbeeck R.K., et al. Modulation of paracetamol metabolism by Kupffer cells: a study on rat liver slices. Life Sci 65 26 (1999) 2851-2859